Polar Capital Holdings PLC Avadel Pharmaceuticals PLC Transaction History

Polar Capital Holdings PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.55 - $17.22 $23,719 - $32,545	1,890 Added 0.03%	6,753,672 $114 Million
Q4 2023 Feb 14, 2024	BUY	$9.64 - $14.59 $21.6 Million - $32.7 Million	2,238,818 Added 49.61%	6,751,782 $95.3 Million
Q3 2023 Nov 14, 2023	SELL	$10.3 - $15.99 $226,157 - $351,092	-21,957 Reduced 0.48%	4,512,964 $46.5 Million
Q2 2023 Dec 13, 2023	SELL	$8.48 - $16.48 $318,585 - $619,137	-37,569 Reduced 0.82%	4,534,921 $74.7 Million
Q2 2023 Aug 14, 2023	SELL	$8.48 - $16.48 $318,585 - $619,137	-37,569 Reduced 0.82%	4,534,921 $74.7 Million
Q1 2023 Dec 13, 2023	BUY	$6.41 - $9.95 $381,561 - $592,283	59,526 Added 1.32%	4,572,490 $41.9 Million
Q1 2023 May 15, 2023	BUY	$6.41 - $9.95 $11.3 Million - $17.5 Million	1,760,000 Added 62.58%	4,572,490 $41.9 Million
Q2 2022 Aug 15, 2022	SELL	$1.07 - $6.95 $413,728 - $2.69 Million	-386,662 Reduced 12.09%	2,812,490 $6.86 Million
Q1 2022 May 16, 2022	BUY	$5.46 - $8.29 $2.21 Million - $3.35 Million	404,479 Added 14.47%	3,199,152 $21.9 Million
Q1 2021 May 17, 2021	SELL	$6.61 - $10.07 $1.54 Million - $2.35 Million	-233,032 Reduced 7.7%	2,794,673 $25.3 Million
Q4 2020 Feb 16, 2021	BUY	$5.03 - $7.95 $15.2 Million - $24.1 Million	3,027,705 New	3,027,705 $20.2 Million

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.